washed ether phase is added to the color reagent (a bivalent mercury/dithizone chelate in chloroform). On addition of diluted pyridine and shaking, a pinkish-violet color appears if a barbiturate is present. The overall sensitivity of the above method was evaluated by probit analysis in the case of sodium phenobarbital. The concentration of sodium phenobarbital in urine detectable at least 99% of the time was 6.72 mg/liter, with 95% confidence limits of 5.37 to 10.36 mg/liter. Sodium phenobarbital, 10 mg/liter, can be detected in the presence of phenytoin (50 mg/liter), glutethimide (100 mg/liter), or bemegride (100 mg/liter). The whole procedure requires <10 mm. An excretion study illustrates application of the procedure. 
Materials and Methods

Reagents
Procedure
Place 5 ml of filtered urine in a 25-ml graduated tube, add about 0.3 g of ammonium bicarbonate and an 5 ml of ether. Extract for 3 mm by gentle inversion (not by shaking).
If an emulsion forms, break it by stirring the organic phase with a wooden rod (the small bubbles of partly released carbon dioxide facilitate the rapid separation of the two phases). Transfer 3 ml of the ether phase into a 15-ml tube, add 3 ml of the diluted pyridine, and shake gently for 15 s. While the water and organic phases are separating, prepare the blank and the test: Place 3 ml of the reagent solution into each of two test tubes, to the blank add 1 ml of ether from the flask, to the test 1 ml of the rinsed ether extract, mix, and add to each tube 3 ml of the diluted pyridine. 
Results
Sensitivity.
Overall sensitivity was assessed as suggested by Gorodetzky (11). These barbiturates all gave about the same results and the amounts excreted were relatively constant for some hours.
Discussion
Preliminary investigations indicate that a complex of barbiturate/mercury/pyridine/dithizone is formed, although further study is needed to establish this. The washing with diluted pyridine must not be omitted because it removes extractable impurities in urine that diminish the sensitivity. It may be generally assumed that the sensitivity for most of the barbiturates will be rather greater than is the case for phenobarbital, because their molecular weights are comparable and they are more efficiently extracted (13). The same may be also assumed for recovery. For example, I measured the following recoveries for some barbiturates:
101.2% ± 11.5 (SD) for amobarbital (n = 6), 97.7% ± 10.0 (SD) for allobarbital (n = 6), 102.6% ± 11.3 (SD) for aprobarbital (n = 6), and 102.2% ± 12.8 (SD) (n = 12) for pentobarbital.
Fifty-seven urine samples from hospitalized or drug-abuse patients have been analyzed in our laboratory by the above method.
The presence or absence of barbiturates was confirmed in all cases by a thinlayer chromatographic analysis. The excretion study demonstrates the suitability of the method for screening for barbiturates.
